News

News

Integrated Translational Pharmaceutics® Program conducted in U.S. With DRGT

Quotient Sciences, and Druggability Technologies (DRGT), a specialty pharmaceutical company, announced a collaboration today to utilize Quotient’s integrated Translational Pharmaceutics® platform to advance the development of DRGT-46, a novel, fast-acting formulation of celecoxib using proprietary super-API compositions developed by DRGT. This will be Quotient’s first Translational Pharmaceutics program delivered from its U.S. operating facilities.

News

Quotient Sciences Increases Spray Drying Capabilities in the U.S.

Quotient Sciences, has invested in additional spray drying capabilities at its formulation development and clinical trial manufacturing facility in Garnet Valley, PA.

News

Quotient Sciences have made a number of submissions through the HRA/MHRA Combined Ways of Working Pilot

The HRA and MHRA have been exploring opportunities to improve the service being offered for the approval and ongoing management of Clinical Trials of Medicinal Products (CTIMPs) and launched a pilot to test an integrated process – the Combined Ways of Working Pilot.

News

Quotient Sciences Significantly Expands Formulation and Manufacturing in UK

Quotient Sciences, a leading drug development services organization, has significantly expanded its formulation development and clinical trial manufacturing operations at its Reading, U.K., facility. The program’s investment has tripled the site’s GMP capacity, added new equipment for solid oral dose manufacturing and significantly increased staffing levels.

Growth

Quotient Sciences Constructs State-of-the-Art Early-Phase Formulation and Manufacturing Facility in U.S.

Quotient Sciences, announces a significant expansion to its operations in the U.S. with the opening of a state-of-the-art, 45,000-square-foot facility located near Philadelphia, in Garnet Valley, Pa. The $15 million investment will create a center of excellence for early-phase formulation development and clinical trial manufacturing.

News

Quotient Sciences is delighted to be taking part in the MHRA / HRA Combined Ways of Working Pilot

We are delighted to be taking part in the MHRA / HRA Combined Ways of Working Pilot and on Friday 22 June 2018 made its first two pilot Phase I submissions.

Latest webinar

Quotient Sciences Completes Million Dollar Pharmacy Expansion at Miami Clinic

Integrated Translational Pharmaceutics® Program conducted in U.S. With DRGT

Quotient Sciences Increases Spray Drying Capabilities in the U.S.

Quotient Sciences have made a number of submissions through the HRA/MHRA Combined Ways of Working Pilot

Quotient Sciences Significantly Expands Formulation and Manufacturing in UK

Quotient Sciences Constructs State-of-the-Art Early-Phase Formulation and Manufacturing Facility in U.S.

Quotient Sciences is delighted to be taking part in the MHRA / HRA Combined Ways of Working Pilot